Cardioviral Proteases and Comparative Genome Structure

心脏病毒蛋白酶和比较基因组结构

• 批准号: 7747911
• 负责人: ANN C. PALMENBERG
• 金额: $ 35.99万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 1980
• 资助国家: 美国
• 起止时间: 1980-12-01 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7747911
• 关键词: Amaze; Antiviral Agents; Back; Binding; Biochemistry; Biology; Brain; Cardiovirus; Cell Nucleolus; Cell Nucleus; Cells; Cessation of life; Complex; Cytoplasm; Disasters; Disease; Encephalomyocarditis virus; Enzyme Precursors; Enzymes; Event; Evolution; Family; Family Picornaviridae; Family member; FarGo; Fertility; Foundations; Genetic Transcription; Genetic Translation; Genome; Goals; Guanosine Triphosphate Phosphohydrolases; Heart; Homologous Gene; Host Defense; Hour; Immune response; Immune system; Individual; Infection; Intestines; Investigation; Laboratories; Lead; Life; Lytic; Messenger RNA; Molecular; Morphogenesis; Mus; Natural Immunity; Nuclear Pore; Nucleic Acids; Occupations; Outcome; Pancreas; Pathway interactions; Peptide Hydrolases; Phase; Phosphorylation; Phosphotransferases; Picornaviridae Infections; Polyproteins; Pore Proteins; Process; Proteins; Proteolytic Processing; RNA; Ribosomes; Running; Signal Transduction; Structural Protein; Structure; System; Translations; Viral; Viral Proteins; Virus; Virus Diseases; War; Work; analog; arm; cohort; comparative; experience; extracellular; falls; fighting; inhibitor/antagonist; intercellular communication; killings; member; novel; nucleocytoplasmic transport; prevent; programs; protein function; public health relevance; research study; spelling; trafficking

DESCRIPTION (provided by applicant): The goals of this investigation are to explore and define the relationship of the cardiovirus genus to other members of the picornavirus family and to exploit the unique features of cardioviruses to examine fundamental molecular questions about picornavirus translation, proteolytic processing, morphogenesis and host interaction. The RNA picornaviruses are one of the best understood and most thoroughly accessible experimental systems in all of biology. Natural infections with cardioviruses, like encephalomyocarditis virus (EMCV), kill nearly every cell in the brain, pancreas and heart of a mouse, within 3 days. The virus does this with apparent impunity to cellular antiviral defenses by subverting innate immunity traps and crippling the capacity of an infected cell to mount a defense or trigger an alarm. The molecular battleground inside infected cells pits viral protease 3Cpro and two unique cardiovirus proteins, L and 2A, enzymes honed by evolution for their special anti-cellular purposes, against the complete array of innate host defenses. The outcome rarely varies. Within 2-3 hours of infection EMCV brings to a halt cellular mRNA transcription, cap-dependent mRNA translation, antiviral signal transduction, and active protein/RNA exchange between the nucleus and cytoplasm. The virus replicates with fecundity and the cell dies before it ever triggers an alarm. At the ultimate molecular level, the activities of these proteins instigate the cascade of events that set off or prevent an episode of disease. The next phase of this project will examine the biochemistry and molecular pathways of EMCV L (Leader), the first viral (or cellular) protein known to bind and inactivate Ran GTPase cycling, the crucial, ubiquitous regulatory system for all protein and nucleic acid trafficking into and out of the nucleus. The project also examines the pathways by which the presence of L, or L-Ran complexes activate a specific cohort of cellular kinases, and redirects them towards the phosphorylation of nuclear pore proteins (Nups). The specific aims are: (1) To resolve the NMR structure of Mengo L (Leader) protein as it interacts with Ran GTPase. (2) To characterize the biochemistry of cardiovirus L:Ran interactions which inhibit RanGDP/GTP cycling in cell-free extracts. (3) To identify within cells, the host kinases activated by L, which contribute to the abrogation of nucleocytoplasmic trafficking steps. (4) To define the molecular interactions of L with other viral proteins (2A and 3CD), and define the replication advantages to cardioviruses, for encoding a unique and potent inhibitor of Ran and of cellular protein and mRNA trafficking. These objectives build directly upon experimental foundations developed during the preceding 27 years of the program. PUBLIC HEALTH RELEVANCE: It is rare to establish productive viral infections that lead to disease if the first infected cells or host immune system are able to fight back effectively. In a war won by stealth, an inadvertant triggering of intracellular or extracellular immunological alarms usually spells disaster (and clearance) for the virus. It's the job of the first viral proteins produced in the first 2-3 hrs of infection, to shutoff essential host response systems. This project examines the molecular pathways for how this happens with RNA picornaviruses in the cardiovirus genus.

描述（由申请方提供）：本研究的目的是探索和确定心脏病毒属与小核糖核酸病毒家族其他成员的关系，并利用心脏病毒的独特特征来研究有关小核糖核酸病毒翻译、蛋白水解加工、形态发生和宿主相互作用的基本分子问题。RNA小核糖核酸病毒是所有生物学中最好理解和最彻底访问的实验系统之一。心脏病毒的自然感染，如脑心肌炎病毒（EMCV），在3天内杀死小鼠大脑，胰腺和心脏中的几乎所有细胞。这种病毒通过破坏先天免疫陷阱和削弱受感染细胞的防御能力或触发警报，对细胞的抗病毒防御明显不受惩罚。感染细胞内的分子战场使病毒蛋白酶3Cpro和两种独特的心脏病毒蛋白L和2A（经过进化而具有特殊的抗细胞目的的酶）与宿主的完整先天防御系统相对抗。结果很少变化。在感染的2-3小时内，EMCV使细胞mRNA转录、帽依赖性mRNA翻译、抗病毒信号转导和细胞核与细胞质之间的活性蛋白/RNA交换停止。病毒以繁殖力进行复制，细胞在触发警报之前就死亡了。在最终的分子水平上，这些蛋白质的活动引发了一连串的事件，引发或预防了疾病的发作。该项目的下一阶段将研究EMCV L（Leader）的生物化学和分子途径，EMCV L是已知的第一种病毒（或细胞）蛋白质，可以结合和调节所有蛋白质和核酸进出细胞核的关键，普遍存在的调节系统。该项目还研究了L或L-Ran复合物激活特定细胞激酶群的途径，并将其重定向到核孔蛋白（Nups）的磷酸化。具体目标是：（1）解析Mengo L（Leader）蛋白与Ran GTPase相互作用时的NMR结构。(2)表征心脏病毒L：Ran相互作用的生物化学，其抑制无细胞提取物中的RanGDP/GTP循环。(3)为了确定细胞内，由L激活的宿主激酶，其有助于废除核质运输步骤。(4)确定L与其他病毒蛋白（2A和3CD）的分子相互作用，并确定对心脏病毒的复制优势，用于编码Ran和细胞蛋白和mRNA运输的独特且有效的抑制剂。这些目标直接建立在该计划前27年开发的实验基础上。公共卫生关系：如果第一个被感染的细胞或宿主免疫系统能够有效地反击，则很少建立导致疾病的生产性病毒感染。在一场靠秘密行动赢得的战争中，细胞内或细胞外免疫警报的意外触发通常意味着病毒的灾难（和清除）。这是在感染的最初2-3小时内产生的第一批病毒蛋白质的工作，以关闭必要的宿主反应系统。该项目研究了心脏病毒属中RNA小核糖核酸病毒如何发生这种情况的分子途径。